Literature DB >> 20585938

Low bone mineral density is associated with increased mortality in elderly men: MrOS Sweden.

H Johansson1, A Odén, J Kanis, E McCloskey, M Lorentzon, Ö Ljunggren, M K Karlsson, E Orwoll, Å Tivesten, C Ohlsson, D Mellström.   

Abstract

SUMMARY: We studied the nature of the relationship between bone mineral density (BMD) and the risk of death among elderly men. BMD was associated with mortality risk and was independent of adjustments for other co-morbidities. A piecewise linear function described the relationship more accurately than assuming the same gradient of risk over the whole range of BMD (p = 0.020). Low BMD was associated with a substantial excess risk of death, whilst a higher than average BMD had little impact on mortality.
INTRODUCTION: Previous studies have demonstrated an association between low BMD and an increased risk of death among men and women. The aim of the present study was to examine the pattern of the risk in men and its relation to co-morbidities.
METHODS: We studied the nature of the relationship between BMD and death among 3,014 elderly men drawn from the population and recruited to the MrOS study in Sweden. Baseline data included general health questionnaires, life style questionnaires and BMD measured using DXA. Men were followed for up to 6.5 years (average 4.5 years). Poisson regression was used to investigate the relationship between BMD, co-morbidities and the hazard function of death.
RESULTS: During follow-up, 382 men died (all-cause mortality). Low BMD at all measured skeletal sites was associated with increased mortality. In multivariate analyses, the relationship between BMD and mortality was non-linear, and a piecewise linear function described the relationship more accurately than assuming the same gradient of risk over the whole range of BMD (p = 0.020).
CONCLUSIONS: Low BMD is associated with a substantial excess risk of death compared to an average BMD, whereas a higher than average BMD has a more modest effect on mortality. These findings, if confirmed elsewhere, have implications for the constructing of probability-based fracture risk assessment tools.

Entities:  

Mesh:

Year:  2010        PMID: 20585938     DOI: 10.1007/s00198-010-1331-1

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  23 in total

Review 1.  FRAX and its applications to clinical practice.

Authors:  John A Kanis; Anders Oden; Helena Johansson; Fredrik Borgström; Oskar Ström; Eugene McCloskey
Journal:  Bone       Date:  2009-02-03       Impact factor: 4.398

2.  Low bone mineral density and mortality in men and women: the Third National Health and Nutrition Examination Survey linked mortality file.

Authors:  Michael E Mussolino; R F Gillum
Journal:  Ann Epidemiol       Date:  2008-09-21       Impact factor: 3.797

3.  Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men.

Authors:  Eric Orwoll; Janet Babich Blank; Elizabeth Barrett-Connor; Jane Cauley; Steven Cummings; Kristine Ensrud; Cora Lewis; Peggy M Cawthon; Robert Marcus; Lynn M Marshall; Joan McGowan; Kathy Phipps; Sherry Sherman; Marcia L Stefanick; Katie Stone
Journal:  Contemp Clin Trials       Date:  2005-10       Impact factor: 2.226

Review 4.  Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.

Authors:  N E Breslow; N E Day
Journal:  IARC Sci Publ       Date:  1987

5.  Predictors of non-spine fracture in elderly men: the MrOS study.

Authors:  Cora E Lewis; Susan K Ewing; Brent C Taylor; James M Shikany; Howard A Fink; Kristine E Ensrud; Elizabeth Barrett-Connor; Steven R Cummings; Eric Orwoll
Journal:  J Bone Miner Res       Date:  2007-02       Impact factor: 6.741

6.  The Physical Activity Scale for the Elderly (PASE): development and evaluation.

Authors:  R A Washburn; K W Smith; A M Jette; C A Janney
Journal:  J Clin Epidemiol       Date:  1993-02       Impact factor: 6.437

Review 7.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1994

8.  Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden.

Authors:  Dan Mellström; Olof Johnell; Osten Ljunggren; Anna-Lena Eriksson; Mattias Lorentzon; Hans Mallmin; Anna Holmberg; Inga Redlund-Johnell; Eric Orwoll; Claes Ohlsson
Journal:  J Bone Miner Res       Date:  2006-04-05       Impact factor: 6.741

9.  The components of excess mortality after hip fracture.

Authors:  J A Kanis; A Oden; O Johnell; C De Laet; B Jonsson; A K Oglesby
Journal:  Bone       Date:  2003-05       Impact factor: 4.398

10.  Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures.

Authors:  D Marshall; O Johnell; H Wedel
Journal:  BMJ       Date:  1996-05-18
View more
  9 in total

1.  Low serum vitamin D is associated with increased mortality in elderly men: MrOS Sweden.

Authors:  H Johansson; A Odén; J Kanis; E McCloskey; M Lorentzon; Ö Ljunggren; M K Karlsson; P M Thorsby; Å Tivesten; E Barrett-Connor; C Ohlsson; D Mellström
Journal:  Osteoporos Int       Date:  2011-10-19       Impact factor: 4.507

2.  Volumetric bone mineral density of the spine predicts mortality in African-American men with type 2 diabetes.

Authors:  L Lenchik; T C Register; G B Russell; J Xu; S C Smith; D W Bowden; J Divers; B I Freedman
Journal:  Osteoporos Int       Date:  2018-05-31       Impact factor: 4.507

3.  Nonlinear association between bone mineral density and all-cause mortality: the Dong-gu study.

Authors:  C K Choi; S -S Kweon; Y -H Lee; H -S Nam; K -S Park; S -Y Ryu; S -W Choi; S A Kim; M -H Shin
Journal:  Osteoporos Int       Date:  2018-07-16       Impact factor: 4.507

4.  Bone Mineral Density of the Radius Predicts All-Cause Mortality in Patients With Type 2 Diabetes: Diabetes Heart Study.

Authors:  Leon Lenchik; Thomas C Register; Fang-Chi Hsu; Jianzhao Xu; S Carrie Smith; J Jeffrey Carr; Barry I Freedman; Donald W Bowden
Journal:  J Clin Densitom       Date:  2017-12-01       Impact factor: 2.617

5.  Low heel ultrasound parameters predict mortality in men: results from the European Male Ageing Study (EMAS).

Authors:  Stephen R Pye; Dirk Vanderschueren; Steven Boonen; Evelien Gielen; Judith E Adams; Kate A Ward; David M Lee; György Bartfai; Felipe F Casanueva; Joseph D Finn; Gianni Forti; Aleksander Giwercman; Thang S Han; Ilpo T Huhtaniemi; Krzysztof Kula; Michael E Lean; Neil Pendleton; Margus Punab; Frederick C Wu; Terence W O'Neill
Journal:  Age Ageing       Date:  2015-07-09       Impact factor: 10.668

6.  The prevalence of moderate to severe radiographic sacroiliitis and the correlation with health status in elderly Swedish men--the MrOS study.

Authors:  Sofia Exarchou; Inga Redlund-Johnell; Magnus Karlsson; Dan Mellström; Claes Ohlsson; Carl Turesson; Lars Erik Kristensen; Lennart Jacobsson
Journal:  BMC Musculoskelet Disord       Date:  2013-12-13       Impact factor: 2.362

Review 7.  Bone function, dysfunction and its role in diseases including critical illness.

Authors:  Nan Su; Jing Yang; Yangli Xie; Xiaolan Du; Hangang Chen; Hong Zhou; Lin Chen
Journal:  Int J Biol Sci       Date:  2019-01-29       Impact factor: 6.580

8.  Improved fracture risk prediction by adding VFA-identified vertebral fracture data to BMD by DXA and clinical risk factors used in FRAX.

Authors:  L Johansson; H Johansson; K F Axelsson; H Litsne; N C Harvey; E Liu; W D Leslie; L Vandenput; E McCloskey; J A Kanis; M Lorentzon
Journal:  Osteoporos Int       Date:  2022-04-22       Impact factor: 5.071

9.  Genetic markers of bone and joint health and physical capability in older adults: the HALCyon programme.

Authors:  Tamuno Alfred; Yoav Ben-Shlomo; Rachel Cooper; Rebecca Hardy; Cyrus Cooper; Ian J Deary; David Gunnell; Sarah E Harris; Meena Kumari; Richard M Martin; Avan Aihie Sayer; John M Starr; Diana Kuh; Ian N M Day
Journal:  Bone       Date:  2012-10-13       Impact factor: 4.398

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.